Global Patient Derived Xenograft/PDX Models Market Professional Survey Report 2017

October 2017 | 114 pages | ID: G2B41B4D3FFEN
QYResearch

Abstracts

This report studies Patient Derived Xenograft/PDX Models in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Crown Bioscience Inc.
• the Jackson Laboratory
• Champions Oncology, Inc.
• Charles River Laboratories International, Inc.
• WuXi Apptec
• ONCODESIGN
• Horizon Discovery Group PLC
• Pharmatest Services Ltd.
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Xentech
• Urolead

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Gastrointestinal Tumor Models
• Gynecological Tumor Models
• Respiratory Tumor Models
• Urological Tumor Models
• Hematological Tumor Models
• Other Tumor Models

By Application, the market can be split into

• Preclinical Drug Development and Basic Cancer Research
• Biomarker Analysis

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Patient Derived Xenograft/PDX Models Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PATIENT DERIVED XENOGRAFT/PDX MODELS

1.1 Definition and Specifications of Patient Derived Xenograft/PDX Models
  1.1.1 Definition of Patient Derived Xenograft/PDX Models
  1.1.2 Specifications of Patient Derived Xenograft/PDX Models
1.2 Classification of Patient Derived Xenograft/PDX Models
  1.2.1 Gastrointestinal Tumor Models
  1.2.2 Gynecological Tumor Models
  1.2.3 Respiratory Tumor Models
  1.2.4 Urological Tumor Models
  1.2.5 Hematological Tumor Models
  1.2.6 Other Tumor Models
1.3 Applications of Patient Derived Xenograft/PDX Models
  1.3.1 Preclinical Drug Development and Basic Cancer Research
  1.3.2 Biomarker Analysis
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PATIENT DERIVED XENOGRAFT/PDX MODELS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Patient Derived Xenograft/PDX Models
2.3 Manufacturing Process Analysis of Patient Derived Xenograft/PDX Models
2.4 Industry Chain Structure of Patient Derived Xenograft/PDX Models

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PATIENT DERIVED XENOGRAFT/PDX MODELS

3.1 Capacity and Commercial Production Date of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016

4 GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Patient Derived Xenograft/PDX Models Capacity and Growth Rate Analysis
  4.2.2 2016 Patient Derived Xenograft/PDX Models Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Patient Derived Xenograft/PDX Models Sales and Growth Rate Analysis
  4.3.2 2016 Patient Derived Xenograft/PDX Models Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Patient Derived Xenograft/PDX Models Sales Price
  4.4.2 2016 Patient Derived Xenograft/PDX Models Sales Price Analysis (Company Segment)

5 PATIENT DERIVED XENOGRAFT/PDX MODELS REGIONAL MARKET ANALYSIS

5.1 North America Patient Derived Xenograft/PDX Models Market Analysis
  5.1.1 North America Patient Derived Xenograft/PDX Models Market Overview
  5.1.2 North America 2012-2017E Patient Derived Xenograft/PDX Models Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Patient Derived Xenograft/PDX Models Sales Price Analysis
  5.1.4 North America 2016 Patient Derived Xenograft/PDX Models Market Share Analysis
5.2 China Patient Derived Xenograft/PDX Models Market Analysis
  5.2.1 China Patient Derived Xenograft/PDX Models Market Overview
  5.2.2 China 2012-2017E Patient Derived Xenograft/PDX Models Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Patient Derived Xenograft/PDX Models Sales Price Analysis
  5.2.4 China 2016 Patient Derived Xenograft/PDX Models Market Share Analysis
5.3 Europe Patient Derived Xenograft/PDX Models Market Analysis
  5.3.1 Europe Patient Derived Xenograft/PDX Models Market Overview
  5.3.2 Europe 2012-2017E Patient Derived Xenograft/PDX Models Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Patient Derived Xenograft/PDX Models Sales Price Analysis
  5.3.4 Europe 2016 Patient Derived Xenograft/PDX Models Market Share Analysis
5.4 Southeast Asia Patient Derived Xenograft/PDX Models Market Analysis
  5.4.1 Southeast Asia Patient Derived Xenograft/PDX Models Market Overview
  5.4.2 Southeast Asia 2012-2017E Patient Derived Xenograft/PDX Models Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Patient Derived Xenograft/PDX Models Sales Price Analysis
  5.4.4 Southeast Asia 2016 Patient Derived Xenograft/PDX Models Market Share Analysis
5.5 Japan Patient Derived Xenograft/PDX Models Market Analysis
  5.5.1 Japan Patient Derived Xenograft/PDX Models Market Overview
  5.5.2 Japan 2012-2017E Patient Derived Xenograft/PDX Models Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Patient Derived Xenograft/PDX Models Sales Price Analysis
  5.5.4 Japan 2016 Patient Derived Xenograft/PDX Models Market Share Analysis
5.6 India Patient Derived Xenograft/PDX Models Market Analysis
  5.6.1 India Patient Derived Xenograft/PDX Models Market Overview
  5.6.2 India 2012-2017E Patient Derived Xenograft/PDX Models Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Patient Derived Xenograft/PDX Models Sales Price Analysis
  5.6.4 India 2016 Patient Derived Xenograft/PDX Models Market Share Analysis

6 GLOBAL 2012-2017E PATIENT DERIVED XENOGRAFT/PDX MODELS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Patient Derived Xenograft/PDX Models Sales by Type
6.2 Different Types of Patient Derived Xenograft/PDX Models Product Interview Price Analysis
6.3 Different Types of Patient Derived Xenograft/PDX Models Product Driving Factors Analysis
  6.3.1 Gastrointestinal Tumor Models of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis
  6.3.2 Gynecological Tumor Models of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis
  6.3.3 Respiratory Tumor Models of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis
  6.3.4 Urological Tumor Models of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis
  6.3.5 Hematological Tumor Models of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis
  6.3.6 Other Tumor Models of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PATIENT DERIVED XENOGRAFT/PDX MODELS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Patient Derived Xenograft/PDX Models Consumption by Application
7.2 Different Application of Patient Derived Xenograft/PDX Models Product Interview Price Analysis
7.3 Different Application of Patient Derived Xenograft/PDX Models Product Driving Factors Analysis
  7.3.1 Preclinical Drug Development and Basic Cancer Research of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis
  7.3.2 Biomarker Analysis of Patient Derived Xenograft/PDX Models Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PATIENT DERIVED XENOGRAFT/PDX MODELS

8.1 Crown Bioscience Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Crown Bioscience Inc. 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Crown Bioscience Inc. 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.2 the Jackson Laboratory
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 the Jackson Laboratory 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 the Jackson Laboratory 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.3 Champions Oncology, Inc.
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Champions Oncology, Inc. 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Champions Oncology, Inc. 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.4 Charles River Laboratories International, Inc.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Charles River Laboratories International, Inc. 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Charles River Laboratories International, Inc. 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.5 WuXi Apptec
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 WuXi Apptec 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 WuXi Apptec 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.6 ONCODESIGN
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 ONCODESIGN 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 ONCODESIGN 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.7 Horizon Discovery Group PLC
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Horizon Discovery Group PLC 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Horizon Discovery Group PLC 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.8 Pharmatest Services Ltd.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Pharmatest Services Ltd. 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Pharmatest Services Ltd. 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.9 Hera Biolabs
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Hera Biolabs 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Hera Biolabs 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.10 EPO Berlin-Buch GmbH
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 EPO Berlin-Buch GmbH 2016 Patient Derived Xenograft/PDX Models Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 EPO Berlin-Buch GmbH 2016 Patient Derived Xenograft/PDX Models Business Region Distribution Analysis
8.11 Xentech
8.12 Urolead

9 DEVELOPMENT TREND OF ANALYSIS OF PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET

9.1 Global Patient Derived Xenograft/PDX Models Market Trend Analysis
  9.1.1 Global 2017-2022 Patient Derived Xenograft/PDX Models Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Patient Derived Xenograft/PDX Models Sales Price Forecast
9.2 Patient Derived Xenograft/PDX Models Regional Market Trend
  9.2.1 North America 2017-2022 Patient Derived Xenograft/PDX Models Consumption Forecast
  9.2.2 China 2017-2022 Patient Derived Xenograft/PDX Models Consumption Forecast
  9.2.3 Europe 2017-2022 Patient Derived Xenograft/PDX Models Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Patient Derived Xenograft/PDX Models Consumption Forecast
  9.2.5 Japan 2017-2022 Patient Derived Xenograft/PDX Models Consumption Forecast
  9.2.6 India 2017-2022 Patient Derived Xenograft/PDX Models Consumption Forecast
9.3 Patient Derived Xenograft/PDX Models Market Trend (Product Type)
9.4 Patient Derived Xenograft/PDX Models Market Trend (Application)

10 PATIENT DERIVED XENOGRAFT/PDX MODELS MARKETING TYPE ANALYSIS

10.1 Patient Derived Xenograft/PDX Models Regional Marketing Type Analysis
10.2 Patient Derived Xenograft/PDX Models International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Patient Derived Xenograft/PDX Models by Region
10.4 Patient Derived Xenograft/PDX Models Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PATIENT DERIVED XENOGRAFT/PDX MODELS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Patient Derived Xenograft/PDX Models
Table Product Specifications of Patient Derived Xenograft/PDX Models
Table Classification of Patient Derived Xenograft/PDX Models
Figure Global Production Market Share of Patient Derived Xenograft/PDX Models by Type in 2016
Figure Gastrointestinal Tumor Models Picture
Table Major Manufacturers of Gastrointestinal Tumor Models
Figure Gynecological Tumor Models Picture
Table Major Manufacturers of Gynecological Tumor Models
Figure Respiratory Tumor Models Picture
Table Major Manufacturers of Respiratory Tumor Models
Figure Urological Tumor Models Picture
Table Major Manufacturers of Urological Tumor Models
Figure Hematological Tumor Models Picture
Table Major Manufacturers of Hematological Tumor Models
Figure Other Tumor Models Picture
Table Major Manufacturers of Other Tumor Models
Table Applications of Patient Derived Xenograft/PDX Models
Figure Global Consumption Volume Market Share of Patient Derived Xenograft/PDX Models by Application in 2016
Figure Preclinical Drug Development and Basic Cancer Research Examples
Table Major Consumers in Preclinical Drug Development and Basic Cancer Research
Figure Biomarker Analysis Examples
Table Major Consumers in Biomarker Analysis
Figure Market Share of Patient Derived Xenograft/PDX Models by Regions
Figure North America Patient Derived Xenograft/PDX Models Market Size (Million USD) (2012-2022)
Figure China Patient Derived Xenograft/PDX Models Market Size (Million USD) (2012-2022)
Figure Europe Patient Derived Xenograft/PDX Models Market Size (Million USD) (2012-2022)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Market Size (Million USD) (2012-2022)
Figure Japan Patient Derived Xenograft/PDX Models Market Size (Million USD) (2012-2022)
Figure India Patient Derived Xenograft/PDX Models Market Size (Million USD) (2012-2022)
Table Patient Derived Xenograft/PDX Models Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Patient Derived Xenograft/PDX Models in 2016
Figure Manufacturing Process Analysis of Patient Derived Xenograft/PDX Models
Figure Industry Chain Structure of Patient Derived Xenograft/PDX Models
Table Capacity and Commercial Production Date of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Patient Derived Xenograft/PDX Models 2012-2017
Figure Global 2012-2017E Patient Derived Xenograft/PDX Models Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Patient Derived Xenograft/PDX Models Market Size (Value) and Growth Rate
Table 2012-2017E Global Patient Derived Xenograft/PDX Models Capacity and Growth Rate
Table 2016 Global Patient Derived Xenograft/PDX Models Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate
Table 2016 Global Patient Derived Xenograft/PDX Models Sales (K Units) List (Company Segment)
Table 2012-2017E Global Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Table 2016 Global Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Patient Derived Xenograft/PDX Models 2012-2017E
Figure North America 2012-2017E Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Figure North America 2016 Patient Derived Xenograft/PDX Models Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Patient Derived Xenograft/PDX Models 2012-2017E
Figure China 2012-2017E Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Figure China 2016 Patient Derived Xenograft/PDX Models Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Patient Derived Xenograft/PDX Models 2012-2017E
Figure Europe 2012-2017E Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Figure Europe 2016 Patient Derived Xenograft/PDX Models Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Patient Derived Xenograft/PDX Models 2012-2017E
Figure Southeast Asia 2012-2017E Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Figure Southeast Asia 2016 Patient Derived Xenograft/PDX Models Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Patient Derived Xenograft/PDX Models 2012-2017E
Figure Japan 2012-2017E Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Figure Japan 2016 Patient Derived Xenograft/PDX Models Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Patient Derived Xenograft/PDX Models 2012-2017E
Figure India 2012-2017E Patient Derived Xenograft/PDX Models Sales Price (USD/Unit)
Figure India 2016 Patient Derived Xenograft/PDX Models Sales Market Share
Table Global 2012-2017E Patient Derived Xenograft/PDX Models Sales (K Units) by Type
Table Different Types Patient Derived Xenograft/PDX Models Product Interview Price
Table Global 2012-2017E Patient Derived Xenograft/PDX Models Sales (K Units) by Application
Table Different Application Patient Derived Xenograft/PDX Models Product Interview Price
Table Crown Bioscience Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Business Region Distribution
Table the Jackson Laboratory Information List
Table Product A Overview
Table Product B Overview
Table 2016 the Jackson Laboratory Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 the Jackson Laboratory Patient Derived Xenograft/PDX Models Business Region Distribution
Table Champions Oncology, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2015 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Business Region Distribution
Table Charles River Laboratories International, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Business Region Distribution
Table WuXi Apptec Information List
Table Product A Overview
Table Product B Overview
Table 2016 WuXi Apptec Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 WuXi Apptec Patient Derived Xenograft/PDX Models Business Region Distribution
Table ONCODESIGN Information List
Table Product A Overview
Table Product B Overview
Table 2016 ONCODESIGN Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 ONCODESIGN Patient Derived Xenograft/PDX Models Business Region Distribution
Table Horizon Discovery Group PLC Information List
Table Product A Overview
Table Product B Overview
Table 2016 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Business Region Distribution
Table Pharmatest Services Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Business Region Distribution
Table Hera Biolabs Information List
Table Product A Overview
Table Product B Overview
Table 2016 Hera Biolabs Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Hera Biolabs Patient Derived Xenograft/PDX Models Business Region Distribution
Table EPO Berlin-Buch GmbH Information List
Table Product A Overview
Table Product B Overview
Table 2016 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Business Region Distribution
Table Xentech Information List
Table Urolead Information List
Figure Global 2017-2022 Patient Derived Xenograft/PDX Models Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Patient Derived Xenograft/PDX Models Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Patient Derived Xenograft/PDX Models Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Patient Derived Xenograft/PDX Models Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Patient Derived Xenograft/PDX Models Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Patient Derived Xenograft/PDX Models Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Patient Derived Xenograft/PDX Models Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Patient Derived Xenograft/PDX Models Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Patient Derived Xenograft/PDX Models by Type 2017-2022
Table Global Consumption Volume (K Units) of Patient Derived Xenograft/PDX Models by Application 2017-2022
Table Traders or Distributors with Contact Information of Patient Derived Xenograft/PDX Models by Region